Inscripta®: Creating the bioeconomy INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING With the addition of Infinome and Sestina Bio, Inscripta adds to its portfolio of cutting-edge technologies for biomanufacturing products for…
Manus and Inscripta merge to create a leader in industrial . . . By combining Inscripta’s advanced whole-genome engineering technologies with Manus’ proven cell factory engineering platform, biomanufacturing expertise, and commercialization capabilities, the merged company – Manus – is
Onyx® Platform - Inscripta lt;sup gt;® lt; sup gt; Inscripta scientists have optimized transformation protocols for E coli and S cerevisiae that are automation-friendly, using a combination of standard and custom techniques adaptations to obtain reproducible transformation
Company History - Inscripta lt;sup gt;® lt; sup gt; Inscripta ® develops innovative, sustainable, and affordable biomanufacturing solutions for a variety of applications and industries, including agriculture, chemicals, animal and human health solutions, personal care, and
dsm-firmenich and Inscripta Announce Strategic Partnership . . . dsm-firmenich, innovators in nutrition, health, and beauty, and biotechnology company Inscripta ® are pleased to announce a strategic partnership in the beauty industry This science-driven collaboration, goes beyond wellbeing
About Us - Inscripta lt;sup gt;® lt; sup gt; Inscripta® develops innovative, sustainable, and affordable biomanufacturing solutions for a variety of applications and industries, including agriculture, chemicals, animal and human health solutions, personal care, and
INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND . . . Inscripta, a global leader in genome engineering technology, announced today the acquisition of two pioneers of synthetic biology – Infinome Biosciences and Sestina Bio, which advance Inscripta’s strategy to develop and